ATE361066T1 - Polyungesättigen fettsäuren nährungsergänzung - Google Patents

Polyungesättigen fettsäuren nährungsergänzung

Info

Publication number: ATE361066T1
Authority: AT; Austria
Prior art keywords: ara; dha; polyunsaturated fatty; fatty acid; nutritional supplement
Prior art date: 1998-10-15

Application number

AT99970319T

Other languages

English (en)

Inventor

Waterschoot Isabel Antonia Van

Hugo Streekstra

Original Assignee

Dsm Ip Assets Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-15

Filing date

1999-10-15

Publication date

2007-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8235104&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE361066(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-10-15 Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE361066T1 publication Critical patent/ATE361066T1/de

Links

235000020777 polyunsaturated fatty acids Nutrition 0.000 title abstract 4
235000015872 dietary supplement Nutrition 0.000 title abstract 2
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 18
229940114079 arachidonic acid Drugs 0.000 abstract 9
235000021342 arachidonic acid Nutrition 0.000 abstract 9
MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 8
235000020669 docosahexaenoic acid Nutrition 0.000 abstract 5
229940090949 docosahexaenoic acid Drugs 0.000 abstract 4
238000009472 formulation Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Addiction (AREA)
Polymers & Plastics (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Food Science & Technology (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Animal Husbandry (AREA)
Pregnancy & Childbirth (AREA)
Rheumatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Obesity (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Zoology (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)

AT99970319T 1998-10-15 1999-10-15 Polyungesättigen fettsäuren nährungsergänzung ATE361066T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98308403		1998-10-15

Publications (1)

Publication Number	Publication Date
ATE361066T1 true ATE361066T1 (de)	2007-05-15

Family

ID=8235104

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99970319T ATE361066T1 (de)	1998-10-15	1999-10-15	Polyungesättigen fettsäuren nährungsergänzung

Country Status (13)

Country	Link
US (2)	US20070184090A1 (de)
EP (4)	EP2308486A1 (de)
JP (2)	JP2002527387A (de)
CN (3)	CN1326344A (de)
AT (1)	ATE361066T1 (de)
AU (2)	AU775421B2 (de)
CA (2)	CA2653503A1 (de)
DE (1)	DE69935995T3 (de)
DK (1)	DK1121115T4 (de)
ES (1)	ES2284286T5 (de)
HK (1)	HK1042441A1 (de)
NZ (1)	NZ511071A (de)
WO (1)	WO2000021524A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0016045D0 (en)	2000-06-29	2000-08-23	Laxdale Limited	Therapeutic combinations of fatty acids
DK1911837T3 (da)	2000-09-28	2011-08-29	Bioriginal Food & Science Corp	FAD5-2 fedtsyredesaturasefamiliemedlem og anvendelser deraf
CA2442692A1 (en) *	2001-03-30	2002-10-10	The Nisshin Oillio, Ltd.	Bone metabolism improving agents
JP2003048831A (ja)	2001-08-02	2003-02-21	Suntory Ltd	脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
AU778384B2 (en) *	2001-11-14	2004-12-02	Virtus Nutrition Llc	Method for manufacturing fatty acid calcium salts from high glyceride content oils
KR102254453B1 (ko) *	2002-06-19	2021-05-21	디에스엠 아이피 어셋츠 비.브이.	미생물 세포와 미생물 오일용 파스퇴르살균 방법
KR101195574B1 (ko) *	2002-09-24	2012-10-30	산토리 홀딩스 가부시키가이샤	아라키돈산을 단독으로 또는 도코사헥사엔산과의 조합으로함유하는 인지 능력 향상용 조성물
US20070037885A1 (en) *	2003-04-25	2007-02-15	Sandra Edwards	Biomass containing animal feed
US8633247B2 (en)	2003-08-11	2014-01-21	Hill's Pet Nutrition, Inc.	Method for decreasing cartilage damage in dogs
US8633246B2 (en)	2003-08-11	2014-01-21	Hill's Pet Nutrition, Inc.	Omega-3 fatty acids for osteoarthritis
EA200602014A1 (ru)	2004-04-30	2007-08-31	ВИРТУС НЬЮТРИШН ЭлЭлСи	Синтез солей одновалентных и двухвалентных металлов полиненасыщенных жирных кислот
JP5667737B2 (ja) *	2004-07-01	2015-02-12	ネステクソシエテアノニム	イヌ変形性関節症食餌製剤
ES2253089B1 (es) *	2004-07-16	2007-08-16	Berthol Victor Laboratorios Ordesa, S.L.	Complemento nutraceutico para la preparacion de leches infantiles.
JP2006083136A (ja) *	2004-09-17	2006-03-30	Suntory Ltd	ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP4993852B2 (ja)	2004-09-17	2012-08-08	サントリーホールディングス株式会社	ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP5967855B2 (ja)	2005-06-30	2016-08-10	サントリーホールディングス株式会社	日中活動量の低下および／又はうつ症状の改善作用を有する組成物
EP1772146A1 (de) *	2005-10-03	2007-04-11	Neuropharma, S.A.	Merfach ungesättigte Fettsäuren als BACE-Inhibitoren
KR101578498B1 (ko)	2006-12-28	2015-12-18	산토리 홀딩스 가부시키가이샤	신경 재생제
US20090202672A1 (en) *	2008-02-11	2009-08-13	Monsanto Company	Aquaculture feed, products, and methods comprising beneficial fatty acids
CN101259101B (zh) *	2008-04-17	2010-06-02	湖北福星生物科技有限公司	微米级花生四烯酸和二十二碳六烯酸乳状液及其制备方法
GB2460056A (en) *	2008-05-14	2009-11-18	Arab Science & Technology Foun	Compositions comprising omega-6 fatty acids for use in treating schistosomiasis
DK2493296T3 (en)	2009-10-30	2019-04-15	Retrotope Inc	REMOVAL OF OXIDATIVE STRESS STATES WITH PUFA DERIVATIVES
US10058522B2 (en) *	2011-04-26	2018-08-28	Retrotope, Inc.	Oxidative retinal diseases
US10154983B2 (en) *	2011-04-26	2018-12-18	Retrotope, Inc.	Neurodegenerative disorders and muscle diseases implicating PUFAs
KR102020579B1 (ko)	2011-04-26	2019-09-10	레트로토프 인코포레이티드	에너지 프로세싱 손상 장애 및 미토콘드리아 결함
WO2012148929A2 (en)	2011-04-26	2012-11-01	Retrotope, Inc.	Disorders implicating pufa oxidation
EP2745706A1 (de) *	2012-12-24	2014-06-25	Abbott Laboratories, Inc.	Verfahren zur Aufrechterhaltung der Knochenqualität
BR112016014262B1 (pt)	2013-12-20	2022-04-05	MARA Renewables Corporation	Método para recuperar lipídeos de uma população de micro-organismos
MA41611A (fr) *	2015-02-23	2018-01-02	Omthera Pharmaceuticals Inc	Préparations en milli-capsules comprenant des acides gras polyinsaturés libres
WO2017091279A1 (en)	2015-11-23	2017-06-01	Retrotope, Inc.	Site-specific isotopic labeling of 1, 4-diene systems
US10851395B2 (en)	2016-06-10	2020-12-01	MARA Renewables Corporation	Method of making lipids with improved cold flow properties
EP3559206B1 (de)	2016-12-22	2025-12-03	Mara Renewables Corporation	Verfahren zur herstellung von biomasse mit hohem gehalt an dha, palmitäure und protein unter verwendung eines eukaryotischen mikroorganismus
EP4107163A4 (de)	2020-02-21	2024-06-19	Retrotope, Inc.	Verfahren zur isotopenmodifizierung von mehrfach ungesättigten fettsäuren und deren derivaten
IL297000A (en)	2020-04-03	2022-12-01	Mara Renewables Corp	Microbial oils with high levels of omega-3 fatty acids
US12109194B2 (en)	2021-02-05	2024-10-08	Biojiva Llc	Synergistic combination therapy for treating ALS
US11491130B2 (en)	2021-02-05	2022-11-08	Retrotope, Inc.	Methods of treating amyotrophic lateral sclerosis
WO2024050589A1 (en) *	2022-09-07	2024-03-14	Nourish Ingredients Pty Ltd	Compositions and methods for producing meat-like aromas
WO2026020071A1 (en) *	2024-07-18	2026-01-22	Red Abbey Labs, Llc	Autogenous therapeutic lipid carriers

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8916734D0 (en) *	1989-07-21	1989-09-06	Efamol Holdings	Pharmaceutical and dietary uses of fatty acids
PH11992043811B1 (en) *	1991-01-24	2002-08-22	Martek Corp	Arachidonic acid and methods for the production and use thereof
US5658767A (en) †	1991-01-24	1997-08-19	Martek Corporation	Arachidonic acid and methods for the production and use thereof
WO1992012711A1 (en) *	1991-01-24	1992-08-06	Martek Corporation	Microbial oil mixtures and uses thereof
JPH0692848A (ja) *	1992-09-11	1994-04-05	Sagami Chem Res Center	糖尿病治療用乳剤
GB9224809D0 (en) *	1992-11-26	1993-01-13	Scotia Holdings Plc	Schizophrenia
JPH06271464A (ja) *	1993-03-19	1994-09-27	Tokiwa Yakuhin Kogyo Kk	消化器系障害の予防または治療用アラキドン酸含有組成物
EP2140863A1 (de) *	1993-06-09	2010-01-06	Martek Biosciences Corporation	Verwendung von Docosahexaensäure zur Herstellung eines Arzneimittels zur Behandlung von neurologischen Störungen
JPH07267856A (ja) *	1994-02-09	1995-10-17	Green Cross Corp:The	経口免疫抑制剤
GB9510636D0 (en) *	1995-05-25	1995-07-19	Scotia Holdings Plc	Fatty acid treatment
WO1996040106A2 (en) *	1995-06-07	1996-12-19	Martek Biosciences Corporation	Methods for controlling highly unsaturated fatty acid content in various tissues
US6200624B1 (en)	1996-01-26	2001-03-13	Abbott Laboratories	Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
DK0969728T4 (da)	1996-03-26	2012-11-19	Dsm Ip Assets Bv	Sen tilsætning af PUFA ved fremstillingsproces for formulering til spædbørn
ES2177966T3 (es)	1996-03-26	2002-12-16	Dsm Nv	Particulas de vehiculos solidos revestidas con acidos grasos poliinsaturados (pufa) para productos alimentarios.
JP2000508888A (ja)	1996-03-28	2000-07-18	ヒスト―ブロカデス・ベスローテン・フェンノートシャップ	低温殺菌したバイオマスからの微生物多不飽和脂肪酸含有オイルの調製
CA2579516A1 (en)	1996-03-28	1997-10-09	Hendrik Louis Bijl	Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom
FR2749133A1 (fr) *	1996-06-04	1997-12-05	Pierre Moreau	Obtention d'oeufs specifiquement enrichis en acide cervonique (acide docosahexaenoique ou dha). applications alimentaires, therapeutiques et industrielles de ces oeufs et de leurs extraits lipidiques
JP3792309B2 (ja) *	1996-08-30	2006-07-05	サントリー株式会社	不飽和脂肪酸含有油脂の製造方法
JP4633204B2 (ja) *	1996-10-11	2011-02-16	サントリーホールディングス株式会社	アラキドン酸含有食用油脂およびそれを含有する食品

1999
- 1999-10-15 CN CN99813303A patent/CN1326344A/zh active Pending
- 1999-10-15 EP EP10174874A patent/EP2308486A1/de not_active Withdrawn
- 1999-10-15 CN CNA2008100998281A patent/CN101283807A/zh active Pending
- 1999-10-15 DE DE69935995T patent/DE69935995T3/de not_active Expired - Lifetime
- 1999-10-15 CA CA002653503A patent/CA2653503A1/en not_active Abandoned
- 1999-10-15 AU AU11520/00A patent/AU775421B2/en not_active Ceased
- 1999-10-15 EP EP07001289A patent/EP1803451A1/de not_active Withdrawn
- 1999-10-15 HK HK02104290.7A patent/HK1042441A1/zh unknown
- 1999-10-15 JP JP2000575500A patent/JP2002527387A/ja active Pending
- 1999-10-15 WO PCT/EP1999/007834 patent/WO2000021524A1/en not_active Ceased
- 1999-10-15 ES ES99970319T patent/ES2284286T5/es not_active Expired - Lifetime
- 1999-10-15 AT AT99970319T patent/ATE361066T1/de not_active IP Right Cessation
- 1999-10-15 EP EP10174886A patent/EP2292223A1/de not_active Withdrawn
- 1999-10-15 DK DK99970319.2T patent/DK1121115T4/da active
- 1999-10-15 CN CN2010105804595A patent/CN102090636A/zh active Pending
- 1999-10-15 EP EP99970319A patent/EP1121115B2/de not_active Expired - Lifetime
- 1999-10-15 CA CA002355341A patent/CA2355341C/en not_active Expired - Fee Related
- 1999-10-15 NZ NZ511071A patent/NZ511071A/en not_active IP Right Cessation
2004
- 2004-10-28 AU AU2004224924A patent/AU2004224924B2/en not_active Ceased
2007
- 2007-03-20 US US11/711,086 patent/US20070184090A1/en not_active Abandoned
2008
- 2008-12-18 US US12/337,969 patent/US20090105342A1/en not_active Abandoned
2010
- 2010-12-01 JP JP2010268487A patent/JP2011098966A/ja active Pending

Also Published As

Publication number	Publication date
EP1803451A1 (de)	2007-07-04
DK1121115T3 (da)	2007-07-02
CN102090636A (zh)	2011-06-15
CN1326344A (zh)	2001-12-12
CA2355341C (en)	2009-04-14
EP1121115A1 (de)	2001-08-08
EP2292223A1 (de)	2011-03-09
EP2308486A1 (de)	2011-04-13
DE69935995D1 (de)	2007-06-14
ES2284286T3 (es)	2007-11-01
HK1042441A1 (zh)	2002-08-16
CN101283807A (zh)	2008-10-15
CA2355341A1 (en)	2000-04-20
DK1121115T4 (da)	2011-01-10
AU2004224924A1 (en)	2004-11-25
ES2284286T5 (es)	2011-01-03
JP2002527387A (ja)	2002-08-27
EP1121115B2 (de)	2010-08-18
NZ511071A (en)	2004-01-30
JP2011098966A (ja)	2011-05-19
US20090105342A1 (en)	2009-04-23
EP1121115B1 (de)	2007-05-02
DE69935995T2 (de)	2008-01-10
US20070184090A1 (en)	2007-08-09
AU1152000A (en)	2000-05-01
CA2653503A1 (en)	2000-04-20
AU775421B2 (en)	2004-07-29
WO2000021524A1 (en)	2000-04-20
AU2004224924B2 (en)	2008-02-28
DE69935995T3 (de)	2011-02-10

Legal Events

Date	Code	Title	Description
2007-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69935995D1 (de)	2007-06-14	Polyungesättigen fettsäuren nährungsergänzung
US5198468A (en)	1993-03-30	Essential fatty acid composition
CA2069600C (en)	2004-05-04	Fatty acid compositions
AU677275B2 (en)	1997-04-17	Formulation for use in smokers
AU618814B2 (en)	1992-01-09	Essential fatty acid compositions
TW200744463A (en)	2007-12-16	Nutritional supplement containing long-chain polyunsaturated fatty acids
NZ505608A (en)	2002-12-20	Fat blend
CA1310911C (en)	1992-12-01	Essential fatty acid compositions
KR900008958A (ko)	1990-07-02	유아용 규정식품에 사용하기 위한 랜덤화된 야자유 지방 조성물
KR940018091A (ko)	1994-08-16	불포화 지방산을 포함하는 처방
EP1211305A4 (de)	2002-11-13	Fettzusammensetzungen
SG143274A1 (en)	2008-06-27	Nutrition containing fat blend
EP0437524B1 (de)	1992-04-15	Triglyceride und nahrungszusammensetzung, die diese enthält
DK1027831T3 (da)	2006-02-20	Stabiliseret fedtstofsammensætning, fremgangsmåde til fremstilling deraf og ernæringsprodukt indeholdende denne
KR100270622B1 (ko)	2000-11-01	영양보급용 영양 조성물
EP0211502A2 (de)	1987-02-25	Verwendung von Linol- oder Linolensäure-Metaboliten zur Behandlung vom prämenstruellen Syndrom
CN1212867A (zh)	1999-04-07	防治心脑血管疾病的组合物